Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,502

Participants

Timeline

Start Date

February 8, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

April 30, 2020

Conditions
Out-Of-Hospital Cardiac Arrest
Interventions
DRUG

Placebo

500 patients will 2 ml of normal saline

DRUG

sodium nitrite 45 mg

500 patients will receive 45 mg IV sodium nitrite

DRUG

sodium nitrite 60 mg

500 patients will receive a dose of 60 mg IV sodium nitrite

Trial Locations (1)

98104

Harborview Medical Center, Seattle

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER

NCT03452917 - Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest | Biotech Hunter | Biotech Hunter